Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results
暂无分享,去创建一个
Léonie Goeminne | Leen Rigouts | Kamela Charmaine Ng | Conor Joseph Meehan | Gabriela Torrea | Maren Diels | Bouke Catherine de Jong | Emmanuel André | L. Rigouts | B. D. de Jong | E. André | L. Goeminne | C. Meehan | M. Diels | G. Torrea | K. C. Ng
[1] Petter Holme,et al. Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination. , 2016, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[2] Thomas R. Ioerger,et al. Genome Analysis of Multi- and Extensively-Drug-Resistant Tuberculosis from KwaZulu-Natal, South Africa , 2009, PloS one.
[3] S. Niemann,et al. Whole genome sequencing for M/XDR tuberculosis surveillance and for resistance testing. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[4] Shane S. Sturrock,et al. Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..
[5] I. Ullah,et al. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study , 2016, BMC Infectious Diseases.
[6] I. Bastian,et al. Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results , 2009, Journal of Clinical Microbiology.
[7] D. Dowdy,et al. The burden of transmitted multi-drug resistance among epidemics of tuberculosis: A transmission model , 2015, The Lancet. Respiratory medicine.
[8] P. de Rijk,et al. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[9] C. D. Long,et al. The Competitive Cost of Antibiotic Resistance in Mycobacterium tuberculosis , 2006, Science.
[10] L. Rigouts,et al. How should discordance between molecular and growth-based assays for rifampicin resistance be investigated? , 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[11] M. Meremikwu,et al. Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria , 2016, International journal of mycobacteriology.
[12] G. Kaplan,et al. A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings , 2016, PloS one.
[13] M. Pai,et al. Tuberculosis Diagnostics: State of the Art and Future Directions. , 2016, Microbiology spectrum.
[14] R. Garfein,et al. Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape , 2016, Antimicrobial Agents and Chemotherapy.
[15] Wen-Yih Chen,et al. The regulation of DNA adsorption and release through chitosan multilayers. , 2014, Carbohydrate polymers.
[16] S. Lawn,et al. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. , 2011, Future microbiology.
[17] E. André,et al. Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[18] George M Church,et al. Tuberculosis Drug Resistance Mutation Database , 2009, PLoS medicine.
[19] D. Alland,et al. Rapid, High-Throughput Detection of Rifampin Resistance and Heteroresistance in Mycobacterium tuberculosis by Use of Sloppy Molecular Beacon Melting Temperature Coding , 2012, Journal of Clinical Microbiology.
[20] K. Dheda,et al. Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments , 2014, Scientific Reports.
[21] F. Cobelens,et al. Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study , 2017, PLoS medicine.
[22] D. Hillemann,et al. Mitigation of Discordant Rifampicin-Susceptibility Results Obtained by Xpert Mycobacterium tuberculosis/Rifampicin and Mycobacterium Growth Indicator Tube. , 2017, Microbial drug resistance.
[23] Alimuddin Zumla,et al. Preventing the spread of multidrug-resistant tuberculosis and protecting contacts of infectious cases. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[24] Razvan Sultana,et al. Genomic Analysis Identifies Targets of Convergent Positive Selection in Drug Resistant Mycobacterium tuberculosis , 2013, Nature Genetics.
[25] L. Rigouts,et al. Rifampin Resistance Missed in Automated Liquid Culture System for Mycobacterium tuberculosis Isolates with Specific rpoB Mutations , 2013, Journal of Clinical Microbiology.
[26] Thomas Abeel,et al. Evolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-Natal , 2015, PLoS medicine.